Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y. Matsushita M, et al. Among authors: okamoto s. Br J Haematol. 2006 Jan;132(1):56-65. doi: 10.1111/j.1365-2141.2005.05843.x. Br J Haematol. 2006. PMID: 16371020 Free article.
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor.
Kanda Y, Hyo R, Yamashita T, Fujimaki K, Oshima K, Onoda M, Mori T, Sakura T, Tanaka M, Sakai M, Taguchi J, Kurakawa M, Maruta A, Okamoto S, Sakamaki H; Kanto Study Group of Cell Therapy. Kanda Y, et al. Among authors: okamoto s. Am J Hematol. 2006 Nov;81(11):838-44. doi: 10.1002/ajh.20710. Am J Hematol. 2006. PMID: 16888784 Free article.
Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y, Nakazato T, Shimizu T, Ikeda Y, Okamoto S. Yamane A, et al. Among authors: okamoto s. Biol Blood Marrow Transplant. 2007 Jan;13(1):100-6. doi: 10.1016/j.bbmt.2006.09.003. Biol Blood Marrow Transplant. 2007. PMID: 17222758 Free article.
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S. Mori T, et al. Among authors: okamoto s. Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006. Biol Blood Marrow Transplant. 2008. PMID: 18489990 Free article.
Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter?
Kanda Y, Okamoto S, Tauchi T, Kizaki M, Inokuchi K, Yabe M, Yokoyama K, Ito Y, Kimura Y, Higashihara M, Bessho M, Ando K, Chiba S, Kurokawa M, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; Tokyo STI Study Group (TSSG). Kanda Y, et al. Among authors: okamoto s. Am J Hematol. 2008 Nov;83(11):835-9. doi: 10.1002/ajh.21274. Am J Hematol. 2008. PMID: 18785644 Free article. Clinical Trial.
Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.
Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, Fujimaki K, Yokota A, Fujisawa S, Matsushima T, Fujita H, Sakura T, Okamoto S, Maruta A, Sakamaki H; Kanto Study Group for Cell Therapy. Oshima K, et al. Among authors: okamoto s. Biol Blood Marrow Transplant. 2008 Oct;14(10):1100-1107. doi: 10.1016/j.bbmt.2008.07.002. Biol Blood Marrow Transplant. 2008. PMID: 18804039 Free article.
Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.
Mori T, Hasegawa K, Okabe A, Tsujimura N, Kawata Y, Yashima T, Kobayashi N, Kondo S, Aisa Y, Kato J, Tsunoda K, Nagai T, Nakagawa T, Shigematsu N, Kubo A, Ikeda Y, Okamoto S. Mori T, et al. Among authors: okamoto s. Int J Hematol. 2008 Dec;88(5):583-587. doi: 10.1007/s12185-008-0181-5. Epub 2008 Oct 30. Int J Hematol. 2008. PMID: 18972188
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sakamaki H, Ishizawa KI, Taniwaki M, Fujisawa S, Morishima Y, Tobinai K, Okada M, Ando K, Usui N, Miyawaki S, Utsunomiya A, Uoshima N, Nagai T, Naoe T, Motoji T, Jinnai I, Tanimoto M, Miyazaki Y, Ohnishi K, Iida S, Okamoto S, Seriu T, Ohno R. Sakamaki H, et al. Among authors: okamoto s. Int J Hematol. 2009 Apr;89(3):332-341. doi: 10.1007/s12185-009-0260-2. Epub 2009 Mar 5. Int J Hematol. 2009. PMID: 19263190 Clinical Trial.
3,072 results